Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1971 4
1974 3
1975 2
1976 6
1977 3
1978 2
1979 2
1980 4
1981 5
1982 2
1983 5
1984 3
1985 4
1986 9
1987 8
1988 8
1989 8
1990 10
1991 9
1992 13
1993 15
1994 2
1995 13
1996 19
1997 8
1998 7
1999 7
2000 15
2001 8
2002 23
2003 28
2004 34
2005 25
2006 35
2007 42
2008 40
2009 42
2010 39
2011 48
2012 44
2013 45
2014 57
2015 71
2016 60
2017 60
2018 59
2019 38
2020 70
2021 60
2022 55
2023 50
2024 49
2025 40

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,168 results

Results by year

Filters applied: . Clear all
Page 1
ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer.
Armstrong AJ, Szmulewitz RZ, Petrylak DP, Holzbeierlein J, Villers A, Azad A, Alcaraz A, Alekseev B, Iguchi T, Shore ND, Rosbrook B, Sugg J, Baron B, Chen L, Stenzl A. Armstrong AJ, et al. Among authors: iguchi t. J Clin Oncol. 2019 Nov 10;37(32):2974-2986. doi: 10.1200/JCO.19.00799. Epub 2019 Jul 22. J Clin Oncol. 2019. PMID: 31329516 Free PMC article. Clinical Trial.
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
Armstrong AJ, Azad AA, Iguchi T, Szmulewitz RZ, Petrylak DP, Holzbeierlein J, Villers A, Alcaraz A, Alekseev B, Shore ND, Gomez-Veiga F, Rosbrook B, Zohren F, Yamada S, Haas GP, Stenzl A. Armstrong AJ, et al. Among authors: iguchi t. J Clin Oncol. 2022 May 20;40(15):1616-1622. doi: 10.1200/JCO.22.00193. Epub 2022 Apr 14. J Clin Oncol. 2022. PMID: 35420921 Free PMC article. Clinical Trial.
IR in Japan.
Iguchi T, Yamakado K. Iguchi T, et al. Cardiovasc Intervent Radiol. 2022 Oct;45(10):1559-1560. doi: 10.1007/s00270-022-03137-8. Epub 2022 Apr 19. Cardiovasc Intervent Radiol. 2022. PMID: 35441244 No abstract available.
En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH.
Kimura M, Iguchi T, Iwasawa K, Dunn A, Thompson WL, Yoneyama Y, Chaturvedi P, Zorn AM, Wintzinger M, Quattrocelli M, Watanabe-Chailland M, Zhu G, Fujimoto M, Kumbaji M, Kodaka A, Gindin Y, Chung C, Myers RP, Subramanian GM, Hwa V, Takebe T. Kimura M, et al. Among authors: iguchi t. Cell. 2022 Oct 27;185(22):4216-4232.e16. doi: 10.1016/j.cell.2022.09.031. Epub 2022 Oct 13. Cell. 2022. PMID: 36240780 Free PMC article.
The periosteum provides a stromal defence against cancer invasion into the bone.
Nakamura K, Tsukasaki M, Tsunematsu T, Yan M, Ando Y, Huynh NC, Hashimoto K, Gou Q, Muro R, Itabashi A, Iguchi T, Okamoto K, Nakamura T, Nakano K, Okamura T, Ueno T, Ito K, Ishimaru N, Hoshi K, Takayanagi H. Nakamura K, et al. Among authors: iguchi t. Nature. 2024 Oct;634(8033):474-481. doi: 10.1038/s41586-024-07822-1. Epub 2024 Aug 21. Nature. 2024. PMID: 39169177
A Novel HER3-Targeting Antibody-Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization.
Hashimoto Y, Koyama K, Kamai Y, Hirotani K, Ogitani Y, Zembutsu A, Abe M, Kaneda Y, Maeda N, Shiose Y, Iguchi T, Ishizaka T, Karibe T, Hayakawa I, Morita K, Nakada T, Nomura T, Wakita K, Kagari T, Abe Y, Murakami M, Ueno S, Agatsuma T. Hashimoto Y, et al. Among authors: iguchi t. Clin Cancer Res. 2019 Dec 1;25(23):7151-7161. doi: 10.1158/1078-0432.CCR-19-1745. Epub 2019 Aug 30. Clin Cancer Res. 2019. PMID: 31471314
Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial.
Azad AA, Petrylak DP, Iguchi T, Shore ND, Villers A, Gomez-Veiga F, Alcaraz A, Alekseev B, Szmulewitz RZ, Holzbeierlein J, Rosbrook B, Ma J, Zohren F, El-Chaar NN, Haas GP, Stenzl A, Armstrong AJ. Azad AA, et al. Among authors: iguchi t. JAMA Netw Open. 2025 May 1;8(5):e258751. doi: 10.1001/jamanetworkopen.2025.8751. JAMA Netw Open. 2025. PMID: 40332939 Free PMC article. Clinical Trial.
Reply by Authors.
Armstrong AJ, Shore ND, Szmulewitz RZ, Petrylak DP, Holzbeierlein J, Villers A, Azad A, Alcaraz A, Alekseev B, Iguchi T, Gomez-Veiga F, Rosbrook B, Lee HJ, Haas GP, Stenzl A. Armstrong AJ, et al. Among authors: iguchi t. J Urol. 2021 May;205(5):1371. doi: 10.1097/JU.0000000000001568.02. Epub 2021 Mar 11. J Urol. 2021. PMID: 33705222 No abstract available.
1,168 results